Global Gene Editing Beyond CRISPR Market (2022 to 2035) - Focus on Zinc Finger Nucleases, Transcription Activator-Like Effector Nucleases and Meganucleases Edited Therapies
22 mars 2022 06h13 HE
|
Research and Markets
Dublin, March 22, 2022 (GLOBE NEWSWIRE) -- The "Gene Editing beyond CRISPR Market: Focus on Zinc Finger Nucleases, Transcription Activator-Like Effector Nucleases and Meganucleases Edited Therapies:...
Global Exosome Development and Manufacturing Services Market Research Report 2022: Current Market Landscape and Likely Future Potential of Exosome Service Providers Over the Next Decade
21 mars 2022 07h13 HE
|
Research and Markets
Dublin, March 21, 2022 (GLOBE NEWSWIRE) -- The "Exosome Development and Manufacturing Services Market, 2022-2035" report has been added to ResearchAndMarkets.com's offering. The "Exosome...
Global Gene Editing Partnering Deals Collection 2010-2022 | Access to 400+ Deals Entered Into by the World's Leading Healthcare Companies
18 mars 2022 07h18 HE
|
Research and Markets
Dublin, March 18, 2022 (GLOBE NEWSWIRE) -- The "Global Gene Editing Partnering Terms and Agreements 2010 to 2022" report has been added to ResearchAndMarkets.com's offering. The Global Gene Editing...
Assessment of the $2.92B Single Cell RNA Sequencing Industry, 2031 - Computational Challenges in Data Analysis of ScRNA Sequencing and a High Capital Requirement Poses Challenges
18 mars 2022 06h48 HE
|
Research and Markets
Dublin, March 18, 2022 (GLOBE NEWSWIRE) -- The "Global Single Cell RNA Sequencing Market - A Global and Regional Analysis: Focus on Product, Workflow, End User and Application, Supply Chain, and...
Global $6+ Billion Cell Therapy Manufacturing Markets, Analysis & Forecasts, 2016-2020 & 2021-2026
16 mars 2022 09h08 HE
|
Research and Markets
Dublin, March 16, 2022 (GLOBE NEWSWIRE) -- The "Global Cell Therapy Manufacturing Market, By Therapy (T-Cell Therapies, Dendritic Cell Therapies, Tumor Cell Therapies, Stem Cell Therapies), By...
Sema4 Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights
14 mars 2022 16h05 HE
|
Sema4
37% increase in fourth quarter test volumes (excluding COVID-19 tests) compared to the same period last year Record quarterly test volume of nearly 83,000 24% growth in fourth quarter revenue...
Global Genomics Market Forecast to Register Compound Annual Growth of 18.2% to Reach $63.50 Billion in 2026
10 mars 2022 05h08 HE
|
Research and Markets
Dublin, March 10, 2022 (GLOBE NEWSWIRE) -- The "Genomics Global Market Report 2022, By Product Type, By Process, By End User" report has been added to ResearchAndMarkets.com's offering. The global...
Sema4 Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2022
08 mars 2022 08h00 HE
|
Sema4
STAMFORD, Conn., March 08, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, has been named to Fast Company’s prestigious annual...
Worldwide High-end Cellomics Industry to 2031 - Analysis, Outlook, Growth, Trends and Forecasts
08 mars 2022 07h08 HE
|
Research and Markets
Dublin, March 08, 2022 (GLOBE NEWSWIRE) -- The "High-end Cellomics - Analysis, Outlook, Growth, Trends, Forecasts 2021-2031" report has been added to ResearchAndMarkets.com's offering. This report...
Cell and Gene Therapy Deals Analysis 2022 - 916 Total Announcements from January 2021 Through January 2022
08 mars 2022 05h43 HE
|
Research and Markets
Dublin, March 08, 2022 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy Deals Analysis" report has been added to ResearchAndMarkets.com's offering. A lot of attention is being given to the areas...